Avillion II (AZ)

Avillion is a clinical co-development company that has collaborated with Pfizer, Merck KGaA and AstraZeneca. Avillion recently announced the publication of positive full results the Mandala phase III trial of AstraZeneca’s PT027 in asthma patients in the NEJM. Avillion has extended its business model to partnering with biotechnology companies in addition to pharmaceutical companies.